Product
SARS-CoV-2 S-Trimer/inactivated SARS-CoV-2
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Safety and Immunogenicity of a Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cell) as Booster Shots in Healthy Adults Aged 18-59 Years Who Have Completed Two Doses of Inactivated SARS-CoV-2 VaccineStatus: Recruiting, Estimated PCD: 2022-12-09